Mephenoxalone
From Wikipedia, the free encyclopedia
 |
|
|
Mephenoxalone
|
|
| Systematic (IUPAC) name | |
| 5-[(2-methoxyphenoxy)methyl]-1,3-oxazolidin-2-one | |
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| Chemical data | |
| Formula | C11H13NO4 |
| Mol. mass | 223.225 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Mephenoxalone is a a muscle relaxant and a mild tranquiliser (anxiolytic) sold under the trade name Dorsiflex®.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||||||||
Mephenoxalone inhibits neuron transmission, that will produce skeletal muscle relaxation by inhibits the reflex arc of skeletal muscle. As the effect of muscle relaxation, mephenoxalone affects mental condition and also a treatment for nervousness,anxiety,nervosity.
